Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular Carcinoma

BACKGROUND AND AIMS: Inflammation affects progression of hepatocellular carcinoma (HCC). We therefore postulate that systemic inflammatory markers could help to predict prognosis in HCC patients receiving sorafenib therapy. METHODS: Overall survival (OS) of HCC patients receiving palliative sorafeni...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Liver Cancer
Auteurs principaux: Sprinzl, Martin F., Kirstein, Martha M., Koch, Sandra, Seib, Marie-Luise, Weinmann-Menke, Julia, Lang, Hauke, Düber, Christoph, Toenges, Gerrit, Zöller, Daniela, Marquardt, Jens U., Wörns, Marcus-Alexander, Galle, Peter R., Vogel, Arndt, Pinter, Matthias, Weinmann, Arndt
Format: Artigo
Langue:Inglês
Publié: S. Karger AG 2019
Sujets:
Original Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6873091/
https://ncbi.nlm.nih.gov/pubmed/31768347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000492628
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires